Self-assessed sexual function after pelvic irradiation for prostate carcinoma: Comparison with an age-matched control group

Cancer

Volumn 78, Issue 5, 1996, Pages 1066-1078

  Fransson, Per ^a   Widmark, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

complications; control group; irradiation; prostate carcinoma; questionnaire; self assessment; sexual function

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CASTRATION; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PENIS ERECTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; SELF REPORT; SEXUAL AROUSAL; SEXUAL DYSFUNCTION;

AGED; AGED, 80 AND OVER; COITUS; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PENILE ERECTION; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; SELF ASSESSMENT (PSYCHOLOGY); SEXUAL BEHAVIOR;

EID: 0029841803     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960901)78:5<1066::AID-CNCR17>3.0.CO;2-0     Document Type: Article

References (82)

1. National Board of Health and Welfare. The Cancer Registry. Cancer Incidence in Sweden 1989. Helsingborg: Schmidts Printing, Inc., 1992; 13-23.
2. Johansson J-E, Adami H-O, Andersson S-O, Bergström R, Krusemo U, Kraaz W. Natural history of localized prostatic cancer. Lancet 1989;ii:879-80.
3. Adolfsson I. Natural course of clinically localized prostate adenocarcinoma in men less than 70 years old. J Urol 1991;146:96-8.
4. Hanks GE, Diamond JJ, Krall JM, Martz KL, Kramer S. A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States. Int J Radiat Oncol Biol Phys 1987;13:499-505.
5. Amdur RJ, Parsons JT, Fitzgerald LT, Million RR. Adenocarcinoma of the prostate treated with external-beam radiation therapy: 5-year minimum follow-up. Radiother Oncol 1990;18:235-46.
6. Sack H, Nosbuesch H, Stuetzer H. Radiotherapy of prostate carcinoma: results of treatment and complications. Radiother Oncol 1987;10:7-15.
7. George NJR. Natural history of localized prostatic cancer managed by conservative therapy alone. Lancet 1988;ii:494-7.
8. Schover LR. Sexual rehabilitation after treatment for prostate cancer. Cancer 1993;71:1024-30.
9. Singer PA, Tasch ES, Stocking C, Rubin S, Siegler M, Weichelbaum R. Sex or survival: trade-offs between quality and quantity of life. J Clin Oncol 1991;9:328-34.
10. Banker FL. The preservation of potency after external bean irradiation for prostate cancer. Int J Radiat Oncol Biol Phys 1988;15:219-20.
11. Bagshaw MA, Cox RS, Ray GR. Status of radiation treatment of prostate cancer at Stanford University. NCI Monogr 1988;7:47-60.
12. Perez CA, Baver W, Garza R, Royce RK. Radiation therapy in the definitive treatment of localized carcinoma of the prostate. Cancer 1977;40:1425-33.
13. Shipley WU, Prout GR Jr., Coachman NM, McManus PL, Healey EA, Althausen AF, et al. Radiation therapy for localized prostate carcinoma: experience at the Massachusetts General Hospital. NCI Monogr 1988;7:67-73.
14. Ray GR, Cassady JR, Bagshaw MA. Definitive radiation therapy of carcinoma of the prostate: a report on 15 years experience. Radiology 1973;106:407-18.
15. Rhamy RK, Wilson SK, Caldwell WL. Biopsy-proven tumor following definitive irradiation for resectable carcinoma of the prostate. J Urol 1972;107:627-30.
16. Schellhammer PF, El-Mahdi AM. Pelvic complications after definitive treatment of prostate cancer by interstitial or external beam radiation. Urology 1983;21:451-7.
17. Zinreich ES, Derogatis LR, Herpst J, Auvil G, Piantadosi S, Order SE. Pre and posttreatment evaluation of sexual function in patients with adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1990;19:729-32.
18. Leiber MM. Surgery vs. radiation for localized prostate cancer. Oncology 1987;1:61-71.
19. 125 implantation of prostate: dose-response considerations. Front Radiat Ther Oncol 1978;12:82-90.
20. Kumar PP, Good R, Rainbolt C, Epstein BE, Chu WK, Jones EO, et al. Low morbidity following transperineal percutaneous template technique for permanent iodine-125 endocurietherapy of prostate cancer. Endocuriether Hyperther Oncol 1986;2:119-26.
21. 125iodine implantation and pelvic lymphadenectomy in the treatment of prostate cancer. J Urol 1979;121:447-51.
22. Kwog EW, Huh SH, Nobler MP, Smith HS. Intraoperative iodine-125 prostatic implant following bilateral pelvic lymphadenectomy. Int J Radiat Oncol Biol Phys 1984; 10:665-70.
23. Whitmore WF, Hilaris B, Grabstald H. Retropubic implantation of iodine-125 in the treatment of prostatic cancer. J Urol 1972;180:918-20.
24. Widmark A, Fransson P, Tavelin B. Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer 1994;74:2520-32.
25. Lindgren B. Stastical theory. 3rd edition. New York: Collier Macmillan, 1989.
26. Skoog I. Sexualitet hos äldre (Sexuality among elderly). In: Lundberg PO. Sexologi. Stockholm: Almqvist & Wiksell Medicin, 1994; 104-13.
27. Finkle AL, Prian DV. Sexual potency in elderly men before and after prostatectomy. JAMA 1966;196:125-9.
28. Andersen BL. Sexual functioning morbidity among cancer survivors. Current status and future research directions. Cancer 1985;55:1835-42.
29. Ofman US, Auchincloss SS. Sexual dysfunction in cancer patients. Curr Opin Oncol 1992;4:605-13.
30. Finkle AL, Moyers TG. Sexual potency in aging males: V. coital ability following open perineal prostatic biopsy. J Urol 1980;84:649-53.
31. Gold FM, Hotchkiss RS. Sexual potency following simple prostatectomy. NY New York J Med 1969;53:2987-9.
32. Holtgrewe HL, Valk WL. Late results of transurethral prostatectomy. J Urol 1964;92:51-5.
33. Madorsky ML, Ashamalla MG, Schussler I, Lyons HR, Miller GH Jr. Sex Maritial Therapy J Urol 1976;115:401-3.
34. Bolt JW, Evans C, Marshall VR. Sexual dysfunction after prostatectomy. Br J Urol 1986;58:319-22.
35. Dixon AR, Lord PH. Sexual functioning following prostatectomy: can impotence and retrograde ejaculation be avoided? Sex Marital Ther 1989;4:127-31.
36. Aaronson NK, Bakker W, Stewart AL, van Dam FSAM, van Zandwijk N, Yarnold JR, et al. Multidimensional approach to the measurement of quality of life in lung cancer clinical trials. In: Aaronson NK, Beckamn J, editors. The Quality of Life of Cancer Patients. New York: Raven Press, 1987:63-82.
37. Tannock I, Gospodarowicz M, Meakin W, Panzarella T, Stewart L, Rider W. Treatment of metastatic prostatic cancer with low dose prednisone: evaluation of pain and quality of life as pragmatic indices of response. J Clin Oncol 1989;7:590-7.
38. Smith JA Jr. Palliation of painful bone metastases from prostate cancer using sodium etidronate: results of a randomized, prospective, double-blind, placebo-controlled study. J Urol 1989;141:85-7.
39. Fossa SD, Aaronson NK, Newling D, van Cangh PJ, Denis L, Kurth K-H, et al. Quality of life and treatment of hormone resistant metastatic prostatic cancer. Eur J Cancer 1990; 26:1133-6.
40. Fossa SD, Aaronson NK, Newling D, van Cangh PJ, Denis L, Kurth KH, et al. Quality of life treatment of hormone resistant metastatic prostatic cancer. Eur J Cancer 1989;26:1133-6.
41. Cull AM. The assessment of sexual function in cancer patients. Eur J Cancer 1992;28:1680-6.
42. da Silva FC, Reis E, Costa T, Denis L. Quality of life in patients with prostatic cancer. A feasibility study. The Members of Quality of Life Committee of the EORTC Genitourinary Group. Cancer 1993;71:1138-42.
43. Bergström-Walan M-B, Nielsen HH. Sexualitet hos 60-80 åringar (Sexuality among the ages 60-80). Nord Sexol 1990;8:137-44.
44. Petros JA, Catalona WJ. Antegrade approach to radical retropubic prostatectomy in patients with difficult apical dissection. J Urol 1991;145:994-7.
45. Pontes JE, Huben R, Wolf R. Sexual function after radical prostatectomy. Prostate 1986;8:123-6.
46. Quinlan DM, Epstein JI, Carter BWS, Walsh PC. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol 1991;145:998-1002.
47. van Heeringen C, De Schryver A, Verbeek E. Sexual function disorders after local radiotherapy for carcinoma of the prostate. Radiother Oncol 1988;13:47-52.
48. Mameghan H, Fisher R, Watt WH, Meagher MJ, Rosen M, Farnsworth RH, et al. Results of radiotherapy for localised prostatic carcinoma treated at the Prince of Wales Hospital, Sydney. Med J Aust 1991;154:317-26.
49. Pilepich MV, Krall JM, al-Sarraf M, John MJ, Doggett RL, Sause WT. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology 1995;45:616-23.
50. Catalona WJ, Dresner SM. Nerve-sparing radical prostatectomy: extraprostatic tumor extension and preservation of erectile function. J Urol 1985;134:1149-51.
51. Eggleston JC, Walsh PC. Radical prostatectomy with preservation of sexual function: pathological findings in the first 100 cases. J Urol 1985;134:1146-8.
52. Lepor H, Walsh PC. Long-term results of radical prostatectomy in clinically localized prostate cancer: experience at The Johns Hopkins Hospital. Monogr Natl Cancer Inst 1988;7:117-22.
53. Jewett HJ. The results of radical perineal prostatectomy. JAMA 1968;210:324-5.
54. Walsh PC, Jewett HJ. Radical surgery for prostatic cancer. Cancer 1980;45:1906-11.
55. Walsh PC. Radical retropubic prostatectomy with reduced morbidity: an anatomic approach. Monogr Natl Cancer Inst 1988;7:133-7.
56. Walsh PC, Lepor H. The role of radical prostatectomy in the management of prostatic cancer. Cancer 1987;60:526-37.
57. Walsh PC, Lepor H, Eggelston JC. Radical prostatectomy with preservation of sexual function. Anatomical and pathological considerations. Prostate 1983;4:473-85.
58. Forman JD, Zinreich ES, Lee DJ, Wharam MD, Baumgarder RA, Order SE. Improving the therapeutic ratio of external beam for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1985;11:2073-80.
59. Mollenkamp JS, Cooper JF, Kagan AR. Clinical experience with supervoltage radiotherapy in carcinoma of the prostate: a preliminary report. J Urol 1975;113:374-7.
60. Loh ES, Brown HE, Beiler DD. Radiotherapy of carcinoma of the prostate: preliminary report. J Urol 1971;106:906-9.
61. Leonard K, Strayker JA. Radiotherapy for prostate carcinoma. J Surg Oncol 1986;33:1-7.
62. Perez CA, Pilepich MV, Garcia D, Simpson JR, Zivnuska F, Hederman MA. Definitive radiation therapy in carcinoma of the prostate localized to the pelvis: experience at the Mallinckrodt Institute of Radiology. Mongr Natl Cancer Inst 1988;7:85-99.
63. Bergman B, Damber JE, Littbrand B, Sjögren K, Tomic R. Sexual function in prostatic cancer patients treated with radiotherapy, orciectomy or oestrogens. Br J Urol 1984;56:64-9.
64. Mittal B. A study of penile circulation before and after radiation in patients with prostate cancer and its effect on impotence. Int J Radiat Oncol Biol Phys 1985;11:1121-5.
65. Kivälä S-L, Pahkala K, Honkakoski A. Sexual desire, intercourse, and related factors among elderly Finns. Nord Sexol 1986;4:18-27.
66. Baker HW. Is there a male menopause? Aust Fam Physician 1984;13:726-8.
67. Johnson JE, Nail LM, Lauver D, King KB, Keys H. Reducing the negative impact of radiation therapy on functional status. Cancer 1988;61:46-51.
68. Mameghan H, Fisher R, Mameghan J, Watt WH, Tynan A. Bowel complications after radiotherapy for carcinoma of the prostate: the volume effect. Int J Radiat Oncol Biol Phys 1990;18:315-20.
69. Hanks GE. External-beam radiation therapy for clinically localized prostate cancer PCS: National practice results of external beam radiation for prostate cancer. Monogr Natl Cancer Inst 1988;7:75-84.
70. Gallagher MJ, Brereton HD, Rostock RA, Zero JM, Zekosky DA, Poyss LF, et al. A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation. Int J Radiat Oncol Biol Phys 1986;12:1565-73.
71. Goldstein I, Feldman MI, Deckers PJ, Babayan RK, Krane RJ. Radiation associated impotence. JAMA 1984;251:903-10.
72. Walsh PC, Brendler CB, Chang T, Marshall FF, Mostwin JI, Stutzman R, et al. Preservation of sexual function in men during radical pelvic surgery. Md Med J 1990;39:389-93.
73. Drago JR, Badalament RA, Nesbitt JA. Radical prostatectomy 1972-1987 single institutional experience: comparison of standard radical prostatectomy and nerve-sparing technique. Urology 1990;35:377-80.
74. Leandri P, Rossignol G, Gautier JR, Ramon J. Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases. J Urol 1992;147:883-7.
75. Pilepich MV, Krall JM, Sause WT, Johnson RJ, Russ HH, Hanks GE, et al. Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate - analysis of RTOG study 75-06. Int J Radiat Oncol Biol Phys 1987;13:351-7.
76. Sandler HM, McShan DL, Lichter AS. Potential improvement in the results of irradiation for prostate carcinoma using improved dose distribution. Int J Radiat Oncol Biol Phys 1991;22:361-7.
77. Sandler HM, Perez-Tamayo C, Ten Haken RK, Lichter AS. Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy. Radiother Oncol 1992;23:53-4.
78. Tait DM, Nahum AE, Rigby L, Chow M, Mayles WP, Dearnaley DP. Conformal radiotherapy of the pelvis: assessment of acute toxicity. Radiother Oncol 1993;29:117-26.
79. Soffen EM, Hanks GE, Hunt MA, Epstein BE. Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques: a reduction in acute morbidity. Int J Radiat Oncol Biol Phys 1992;24:485-8.
80. Hanks GE. Conformal radiation in prostate cancer: reduced morbidity with hope of increased local control [editorial; comment]. Int J Radiat Oncol Biol Phys 1993;25:377-8.
81. Kaiser FE. Sexual function and the older cancer patient. Oncology 1992;6:112-8.
82. Korenman SG, Morley JE, Mooradian AD, Davis SS, Kaiser FE, Silver AJ, et al. Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab 1990; 71:963-9.